Genomma Lab Internacional Stock Market Value

GNMLF Stock  USD 1.27  0.00  0.00%   
Genomma Lab's market value is the price at which a share of Genomma Lab trades on a public exchange. It measures the collective expectations of Genomma Lab Internacional investors about its performance. Genomma Lab is trading at 1.27 as of the 29th of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.27.
With this module, you can estimate the performance of a buy and hold strategy of Genomma Lab Internacional and determine expected loss or profit from investing in Genomma Lab over a given investment horizon. Check out Genomma Lab Correlation, Genomma Lab Volatility and Genomma Lab Alpha and Beta module to complement your research on Genomma Lab.
Symbol

Please note, there is a significant difference between Genomma Lab's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genomma Lab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genomma Lab's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Genomma Lab 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Genomma Lab's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Genomma Lab.
0.00
12/10/2022
No Change 0.00  0.0 
In 1 year 11 months and 21 days
11/29/2024
0.00
If you would invest  0.00  in Genomma Lab on December 10, 2022 and sell it all today you would earn a total of 0.00 from holding Genomma Lab Internacional or generate 0.0% return on investment in Genomma Lab over 720 days. Genomma Lab is related to or competes with Hypera SA, Cumberland Pharmaceuticals, Orexo AB, C21 Investments, Alpha Teknova, Lifecore Biomedical, and Organogenesis Holdings. Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sa... More

Genomma Lab Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Genomma Lab's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Genomma Lab Internacional upside and downside potential and time the market with a certain degree of confidence.

Genomma Lab Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Genomma Lab's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Genomma Lab's standard deviation. In reality, there are many statistical measures that can use Genomma Lab historical prices to predict the future Genomma Lab's volatility.
Hype
Prediction
LowEstimatedHigh
0.061.275.63
Details
Intrinsic
Valuation
LowRealHigh
0.050.935.29
Details
Naive
Forecast
LowNextHigh
0.021.245.60
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.081.221.35
Details

Genomma Lab Internacional Backtested Returns

Genomma Lab appears to be extremely dangerous, given 3 months investment horizon. Genomma Lab Internacional holds Efficiency (Sharpe) Ratio of 0.12, which attests that the entity had a 0.12% return per unit of risk over the last 3 months. By evaluating Genomma Lab's technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please utilize Genomma Lab's Standard Deviation of 5.59, market risk adjusted performance of 0.8417, and Risk Adjusted Performance of 0.0812 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Genomma Lab holds a performance score of 9. The company retains a Market Volatility (i.e., Beta) of 0.63, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Genomma Lab's returns are expected to increase less than the market. However, during the bear market, the loss of holding Genomma Lab is expected to be smaller as well. Please check Genomma Lab's variance, potential upside, as well as the relationship between the Potential Upside and day median price , to make a quick decision on whether Genomma Lab's current trending patterns will revert.

Auto-correlation

    
  0.08  

Virtually no predictability

Genomma Lab Internacional has virtually no predictability. Overlapping area represents the amount of predictability between Genomma Lab time series from 10th of December 2022 to 5th of December 2023 and 5th of December 2023 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Genomma Lab Internacional price movement. The serial correlation of 0.08 indicates that barely 8.0% of current Genomma Lab price fluctuation can be explain by its past prices.
Correlation Coefficient0.08
Spearman Rank Test0.21
Residual Average0.0
Price Variance0.04

Genomma Lab Internacional lagged returns against current returns

Autocorrelation, which is Genomma Lab pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Genomma Lab's pink sheet expected returns. We can calculate the autocorrelation of Genomma Lab returns to help us make a trade decision. For example, suppose you find that Genomma Lab has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Genomma Lab regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Genomma Lab pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Genomma Lab pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Genomma Lab pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Genomma Lab Lagged Returns

When evaluating Genomma Lab's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Genomma Lab pink sheet have on its future price. Genomma Lab autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Genomma Lab autocorrelation shows the relationship between Genomma Lab pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Genomma Lab Internacional.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Genomma Pink Sheet

Genomma Lab financial ratios help investors to determine whether Genomma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genomma with respect to the benefits of owning Genomma Lab security.